Evidence map›Paper›PMID 40115305›Full record

ArticleRevista Cuidarte

Analysis of complications associated with peripherally inserted central venous catheters. Prospective observational study.

Marta Ferraz-Torres, Ana Diez-Revilla, Ruth Plaza-Unzue, Maria Inés Corcuera-Martinez

Abstract read
In one paragraph

Article in Revista Cuidarte. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marta Ferraz-TorresPhD, MMCE, RN, University Hospital of Navarra, Navarra, Spain. Associate professor, Department of Health Sciences, Public University of Navarre, E-mail: marta.ferraz@unavarra.esResearcher, IdiSNA, Navarra Institute for Health Research Universidad de Navarra Department of Health Sciences Public University of Navarre Navarra Spain marta.ferraz@unavarra.es.
Ana Diez-RevillaRN, University Hospital of Navarra, Navarra, Spain. E-mail: ana.diez.revilla@navarra.es Universidad de Navarra University Hospital of Navarra Navarra Spain ana.diez.revilla@navarra.es.
Ruth Plaza-UnzueRN, University Hospital of Navarra, Navarra, Spain. E-mail: ruth.plaza.unzue@navarra.es Universidad de Navarra University Hospital of Navarra Navarra Spain ruth.plaza.unzue@navarra.es.
Maria Inés Corcuera-MartinezRN, Hospital University Hospital of Navarra, Navarra, Spain. E-mail: ines.corcuera.martinez@navarra.es Universidad de Navarra University Hospital of Navarra Navarra Spain ines.corcuera.martinez@navarra.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vascular access teams often use guidelines or algorithms to determine the most appropriate vascular access device based on the patient's condition and the substance to be infused. These guidelines are intended to help identify the most qualified personnel for device insertion, but few studies collect information on the performance of these units. Objective: This study aims to identify the evolution and complication rate of peripherally inserted central catheters (PICCs) in patients requiring vascular access. Materials and Methods: A prospective observational study was conducted over three years. Continuous variables with normal distribution were compared using Student's t-test. Nonparametrically distributed variables were analyzed with the Mann-Whitney U test. For categorical variables, the two-tailed chi-square or Fisher's exact test was used. Regression analysis was performed for the dependent variable of complications. Results: Of the PICCs inserted, 61.99% (566) were in patients receiving oncologic treatment, with a mean dwell time of 136±127.51 days. PICCs inserted in hematologic patients had a mean dwell time of 144±141.3 days (p=0.438). The most frequent complications were accidental removal (3.50%, 32, OR 0.581), thrombosis (3%, 27, OR 0.752), and central line-associated bloodstream infection (CLABSI) (2.10%, 19, OR, 0.113). Discussion: Complications related to PICCs were infrequent, with thrombosis being the most prevalent. Accidental removal was also frequent, a complication not thoroughly analyzed in other studies. Conclusions: PICC insertion and management by vascular access teams enables units to achieve a low complication rate in onco-hematological patients.

Indexed as

HematologyNursing TeamOncologyTreatmentVascular Access

Identifiers

PMID40115305
PMCPMC11922584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.